Pentwater Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Pentwater Capital Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,744,819	Closed	-$34.7M	–	175
2023 Q1	$34.7M	Buy	+1,744,819	New	+$30.1M	0.34%	51
2020 Q4	–	Sell	-44,977	Closed	-$1.77M	–	275
2020 Q3	$1.77M	Sell	44,977 -5,023	-10%	-$162K	0.02%	128
2020 Q2	$1.58M	Buy	+50,000	New	+$1.87M	0.03%	88

Other funds holding CSII

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pentwater Capital Management's CSII Position: Q2 2023 in Review

Pentwater Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 1,744,819 shares — an estimated $34.7M sold.

Pentwater Capital Management first reported a position in CSII in Q2 2020 and held it in 3 quarters. The position peaked at $34.7M in Q1 2023. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Pentwater Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Pentwater Capital Management sold 1,744,819 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $34.7M.
Pentwater Capital Management first reported a position in Cardiovascular Systems, Inc. in Q2 2020 and held it in 3 quarters.
Pentwater Capital Management's Cardiovascular Systems, Inc. position peaked at $34.7M in Q1 2023.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Pentwater Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.